What is the most recent earnings date for NAGE stock?
NIAGEN BIOSCIENCE INC (NAGE) last reported earnings on 3/4/2026.
NASDAQ:NAGE • US1710774076
Past quarterly earnings results for NIAGEN BIOSCIENCE INC (NAGE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.03 | 0.02 | 33.69% | -66.67% | 33.839M | 32.335M | 4.65% | 16.19% |
| Q3 2025 | 0.05 | 0.02 | 206.37% | 150.00% | 33.986M | 31.724M | 7.13% | 32.86% |
| Q2 2025 | 0.04 | 0.01 | 180.11% | - | 31.117M | 28.89M | 7.71% | 36.84% |
| Q1 2025 | 0.06 | 0.02 | 252.87% | 700.00% | 30.481M | 27.642M | 10.27% | 37.59% |
| Q4 2024 | 0.09 | 0.02 | 341.18% | - | 29.125M | 27.268M | 6.81% | 37.41% |
| Q3 2024 | 0.02 | 0.00 | 488.82% | 300.00% | 25.58M | 24.116M | 6.07% | 31.18% |
| Q2 2024 | 0.00 | -0.02 | 100.00% | 100.00% | 22.739M | 23.905M | -4.88% | 11.90% |
| Q1 2024 | -0.01 | -0.02 | 41.19% | 66.67% | 22.153M | 24.449M | -9.39% | -1.80% |
| Q4 2023 | 0.00 | -0.03 | 100.00% | 100.00% | 21.196M | 21.403M | -0.97% | 0.93% |
| Q3 2023 | -0.01 | -0.03 | 69.83% | 75.00% | 19.5M | 20.654M | -5.59% | 14.30% |
| Q2 2023 | -0.03 | -0.04 | 21.57% | 66.67% | 20.32M | 19.572M | 3.82% | 21.46% |
| Q1 2023 | -0.03 | -0.05 | 38.73% | 72.73% | 22.56M | 19.708M | 14.47% | 30.71% |
| Q4 2022 | -0.02 | -0.02 | 18.88% | 75.00% | 21M | 21.559M | -2.59% | 18.24% |
| Q3 2022 | -0.04 | -0.06 | 36.75% | 69.23% | 17.06M | 19.061M | -10.50% | -1.44% |
| Q2 2022 | -0.09 | -0.09 | -3.81% | -12.50% | 16.73M | 19.019M | -12.04% | -5.48% |
| Q1 2022 | -0.11 | -0.09 | -17.22% | 8.33% | 17.26M | 17.573M | -1.78% | 17.57% |
| Q4 2021 | -0.08 | -0.10 | 21.57% | 20.00% | 17.76M | 18.94M | -6.23% | 14.95% |
| Q3 2021 | -0.13 | -0.09 | -38.53% | -85.71% | 17.31M | 17.519M | -1.19% | 22.07% |
| Q2 2021 | -0.08 | -0.08 | 4.35% | -33.33% | 17.7M | 17.501M | 1.14% | 15.76% |
| Q1 2021 | -0.12 | -0.09 | -36.80% | -20.00% | 14.68M | 17.015M | -13.72% | 2.30% |
| Q4 2020 | -0.10 | -0.10 | -3.20% | - | 15.45M | 15.671M | -1.41% | - |
| Q3 2020 | -0.07 | -0.10 | 29.97% | - | 14.18M | 14.579M | -2.74% | - |
| Q2 2020 | -0.06 | -0.11 | 43.98% | - | 15.29M | 14.148M | 8.07% | - |
| Q1 2020 | -0.10 | -0.11 | 12.85% | - | 14.35M | 14.035M | 2.24% | - |
Notes
NIAGEN BIOSCIENCE INC (NAGE) last reported earnings on 3/4/2026.
NIAGEN BIOSCIENCE INC (NAGE) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, NIAGEN BIOSCIENCE INC (NAGE) has beaten EPS estimates in 4 out of 4 releases.